microRNAs: A new frontier in kallikrein research

Biological Chemistry

Volumn 389, Issue 6, 2008, Pages 689-694

  Yousef, George M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Bioinformatics; Kallikrein; KLK; microRNA; RNAi; Target validation

Indexed keywords

KALLIKREIN; MICRORNA; TUMOR MARKER;

CHROMOSOMAL LOCALIZATION; CONFERENCE PAPER; HUMAN; HUMAN GENOME; MULTIGENE FAMILY; PRIORITY JOURNAL; TUMOR GROWTH;

CHROMOSOMES, HUMAN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; MICRORNAS; NEOPLASMS; RESEARCH;

EID: 47549096619     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.068     Document Type: Conference Paper

References (57)

1. Allawi, H.T., Dahlberg, J.E., Olson, S., Lund, E., Olson, M., Ma, W.P., Takova, T., Neri, B.P., and Lyamichev, V.I. (2004). Quantitation of microRNAs using a modified Invader assay. RNA 10, 1153-1161.
2. Ambros, V., Bartel, B., Bartel, D.P., Burge, C.B., Carrington, J.C., Chen, X., Dreyfuss, G., Eddy, S.R., Griffiths-Jones, S., Marshall, M., et al. (2003). A uniform system for microRNA annotation. RNA 9, 277-279.
3. Babak, T., Zhang, W., Morris, Q., Blencowe, B.J., and Hughes, T.R. (2004). Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 10, 1813-1819.
4. Bando, Y., Ito, S., Nagai, Y., Terayama, R., Kishibe, M., Jiang, Y.P., Mitrovic, B., Takahashi, T., and Yoshida, S. (2006). Implications of protease M/neurosin in myelination during experimental demyelination and remyelination. Neurosci. Lett. 405, 175-180.
5. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
6. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
7. Burgler, C. and Macdonald, P.M. (2005). Prediction and verification of microRNA targets by MovingTargets, a highly adaptable prediction method. BMC Genomics 6, 88.
8. Calin, G.A. and Croce, C.M. (2006a). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 66, 7390-7394.
9. Calin, G.A. and Croce, C.M. (2006b). MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25, 6202-6210.
10. Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99, 15524-15529.
11. Chan, J.A., Krichevsky, A.M., and Kosik, K.S. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033.
12. Chow, T.-f.F., Crow, M., Earle, T., El-Said, H., Diamandis, E.P., and Yousef, G.M. (2008). Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biol. Chem. 389, 731-738.
13. Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265-312.
14. Croce, C.M. and Calin, G.A. (2005). miRNAs, cancer, and stem cell division. Cell 122, 6-7.
15. Cullen, B.R. (2004). Transcription and processing of human microRNA precursors. Mol. Cell 16, 861-865.
16. Diamandis, E.P., Yousef, G.M., and Olsson, A.Y. (2004). An update on human and mouse glandular kallikreins. Clin. Biochem. 37, 258-260.
17. Emami, N. and Diamandis, E.P. (2007). Human tissue kallikreins: a road under construction. Clin. Chim. Acta 381, 78-84.
18. Esau, C.C. and Monia, B.P. (2007). Therapeutic potential for microRNAs. Adv. Drug Deliv. Rev. 59, 101-114.
19. Esquela-Kerscher, A. and Slack, F.J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
20. Harris, A.L. (2002). Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47.
21. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J., and Hammond, S.M. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833.
22. Horii, K., Suzuki, Y., Kondo, Y., Akimoto, M., Nishimura, T., Yamabe, Y., Sakaue, M., Sano, T., Kitagawa, T., Himeno, S., et al. (2007). Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol. Cancer Res. 5, 383-391.
23. Jiang, J., Lee, E.J., Gusev, Y., and Schmittgen, T.D. (2005). Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 33, 5394-5403.
24. Klokk, T.I., Kilander, A., Xi, Z., Waehre, H., Risberg, B., Danielsen, H.E., and Saatcioglu, F. (2007). Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res. 67, 5221-5230.
25. Kluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B.J., and van den Berg, A. (2005). BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207, 243-249.
26. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M., and Rajewsky, N. (2005). Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500.
27. Kulshreshtha, R., Ferracin, M., Negrini, M., Calin, G.A., Davuluri, R.V., and Ivan, M. (2007a). Regulation of microRNA expression: the hypoxic component. Cell Cycle 6, 1426-1431.
28. Kulshreshtha, R., Ferracin, M., Wojcik, S.E., Garzon, R., Alder, H., Agosto-Perez, F.J., Davuluri, R., Liu, C.G., Croce, C.M., Negrini, M., et al. (2007b). A microRNA signature of hypoxia. Mol. Cell Biol. 27, 1859-1867.
29. Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1-14.
30. Lai, E.C. (2004). Predicting and validating microRNA targets. Genome Biol. 5, 115.
31. Lee, E.J., Gusev, Y., Jiang, J., Nuovo, G.J., Lerner, M.R., Frankel, W.L., Morgan, D.L., Postier, R.G., Brackett, D.J., and Schmittgen, T.D. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120, 1046-1054.
32. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. (2003). Prediction of mammalian microRNA targets. Cell 115, 787-798.
33. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
34. Meltzer, P.S. (2005). Cancer genomics: small RNAs with big impacts. Nature 435, 745-746.
35. Metzler, M., Wilda, M., Busch, K., Viehmann, S., and Borkhardt, A. (2004). High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39, 167-169.
36. Michael, M.Z., O'Connor, S.M., Holst Pellekaan, N.G., Young, G.P., and James, R.J. (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1, 882-891.
37. Nelson, P.T., Baldwin, D.A., Scearce, L.M., Oberholtzer, J.C., Tobias, J.W., and Mourelatos, Z. (2004). Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods 1, 155-161.
38. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., and Mendell, J.T. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843.
39. Paliouras, M. and Diamandis, E.P. (2007). Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res. Treat. 102, 7-18.
40. Paliouras, M., Borgono, C., and Diamandis, E.P. (2007). Human tissue kallikreins: the cancer biomarker family. Cancer Lett. 249, 61-79.
41. Pampalakis, G. and Sotiropoulou, G. (2006). Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol. Chem. 387, 773-782.
42. Puddu, G.M., Cravero, E., Ferrari, E., Muscari, A., and Puddu, P. (2007). Gene-based therapy for hypertension - do preclinical data suggest a promising future? Cardiology 108, 40-47.
43. Schmittgen, T.D., Jiang, J., Liu, Q., and Yang, L. (2004). A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 32, e43.
44. Shinoda, Y., Kozaki, K., Imoto, I., Obara, W., Tsuda, H., Mizutani, Y., Shuin, T., Fujioka, T., Miki, T., and Inazawa, J. (2007). Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci. 98, 1078-1086.
45. Sun, Y., Koo, S., White, N., Peralta, E., Esau, C., Dean, N.M., and Perera, R.J. (2004). Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 32, e188.
46. Szafranska, A.E., Davison, T.S., John, J., Cannon, T., Sipos, B., Maghnouj, A., Labourier, E., and Hahn, S.A. (2007). MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26, 4442-4452.
47. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756.
48. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261.
49. Wienholds, E. and Plasterk, R.H. (2005). MicroRNA function in animal development. FEBS Lett. 579, 5911-5922.
50. Wu, W., Sun, M., Zou, G.M., and Chen, J. (2007). MicroRNA and cancer: current status and prospective. Int. J. Cancer 120, 953-960.
51. Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R.A., Schechter, N.M., Bonnart, C., Descargues, P., Hovnanian, A., and Gallo, R.L. (2006). Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068-2080.
52. Yousef, G.M. and Diamandis, E.P. (2002). Expanded human tissue kallikrein family - a novel panel of cancer biomarkers. Tumour Biol. 23, 185-192.
53. Yousef, G.M., Chang, A., Scorilas, A., and Diamandis, E.P. (2000). Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125-133.
54. Yousef, G.M., Kopolovic, A.D., Elliott, M.B., and Diamandis, E.P. (2003a). Genomic overview of serine proteases. Biochem. Biophys. Res. Commun. 305, 28-36.
55. Yousef, G.M., Polymeris, M.E., Yacoub, G.M., Scorilas, A., Soosaipillai, A., Popalis, C., Fracchioli, S., Katsaros, D., and Diamandis, E.P. (2003b). Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 63, 2223-2227.
56. Yousef, G.M., Obiezu, C.V., Luo, L.Y., Magklara, A., Borgono, C.A., Kishi, T., Memari, N., Michael, P., Sidiropoulos, M., Kurlender, L., et al. (2005). Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem. 39, 11-79.
57. Yu, J., Wang, F., Yang, G.H., Wang, F.L., Ma, Y.N., Du, Z.W., and Zhang, J.W. (2006). Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem. Biophys. Res. Commun. 349, 59-68.